This story was originally published by Men's Journal on Jan 5, 2026, where it first appeared in the Health & Fitness section
GLP-1 is secreted by intestinal L cells in response to food intake and promotes satiety, reduces food consumption, and delays gastric emptying through actions on the hypothalamus ( The theoretical rationale of the present study is grounded in emerging evidence that GLP-1 signaling extends beyond metabolic regulation and may influence reward processing and addiction-related neural circuits ( Importantly, this trial enrolls patients with T2DM receiving routine glucose-lowering therapy, thereby reflecting real-world clinical practice

As a Liraglutide goes by the following brand names: Saxenda (liraglutide 3.0 mg daily subcutaneous injection) is the only brand with FDA approval for chronic weight management in the adults with obesity adults with overweight and at least one weight-related health condition A Tirzepatide Tirzepatide activates GLP-1 receptors and glucose-dependent insulinotropic polypeptide (GIP), an intestinal hormone that In 2023, the adults with obesity adults with overweight and at least one weight-related condition Zepbound is both a GLP-1 receptor agonist and a GIP receptor agonist, so it helps reduce appetite and food intake
Local Access Across Central Florida Follow-through is part of outcomes
Eating foods that also help boost satiety and maintain a healthy weight and blood sugar can therefore maximize the effects of these medications